摘要
在急性脑缺血的超早期,完整的血脑屏障(BBB)使许多治疗药物无法在有效治疗时间窗内进入脑组织发挥作用。转铁蛋白受体(TfR)单克隆抗体能有效通过受体介导的细胞内吞作用使结合的药物通过BBB,从而大大增加了治疗药物的定向选择性,使之更好地发挥治疗作用。
In the super early phase of acute cerebral ischemia, many therapeutic drugs cannot penetrate into the complete blood-brain barrier (BBB) and enter brain tissues within the effective time window. The transferrin receptor(TfR) monoclonal antibodies can effectively penetrate BBB via receptor-mediated endocytosis and make the combined drugs penetrate BBB, and thus increasing the orientation selectivity of the therapeutic drugs considerably, and developing their better therapeutic effect.
出处
《国外医学(脑血管疾病分册)》
2004年第4期301-303,共3页
Foreign Medical Sciences Cerebrovascular Diseases